Compare MIST & NIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIST | NIU |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.9M | 147.5M |
| IPO Year | 2019 | 2018 |
| Metric | MIST | NIU |
|---|---|---|
| Price | $0.78 | $1.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $5.86 | $2.54 |
| AVG Volume (30 Days) | ★ 1.4M | 273.9K |
| Earning Date | 11-11-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $147.62 | $20.29 |
| Revenue Next Year | $476.43 | $22.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.75 | $1.79 |
| 52 Week High | $3.06 | $5.66 |
| Indicator | MIST | NIU |
|---|---|---|
| Relative Strength Index (RSI) | 31.05 | 44.48 |
| Support Level | $0.75 | $1.90 |
| Resistance Level | $1.42 | $2.04 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 13.44 | 32.89 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Niu Technologies designs, manufactures, and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycles, mopeds, and bicycle series, including the NQi, MQi, UQi, FQi series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.